First author [ref.] | Samples n | Country | Setting | Date of study | Study design | Reference standard | Sample type | CD4 count cells·μL−1 | Females % | Mean age years | Symptoms |
Reddy [30] | 889 | Peru | Urban | February 2007–December 2007 | Cross-sectional | L-J | Sputum | Mean±sd 241±184 | 37.2 | 34 | Absent |
Vargas [31] | 212 | Peru | Urban | April 2002–October 2003 | Case–control | L-J | Induced sputum, string | Median 52.9 | NR | NR | Present |
Ha [32] | 738 | Vietnam | Urban | May 2008–November 2008 | Cross-sectional | MGIT | Sputum | NR | 1.9 | 29 | Present |
Caws [35] | 88 | Vietnam | Urban | June 2006–November 2006 | Cross-sectional | MGIT and L-J | CSF | NR | NR | NR | Present |
Ha [36] | 17 | Vietnam | Urban | April 2008–November 2008 | Cross-sectional | MGIT | Sputum, gastric aspirates, pleural fluid, CSF | NR | 4.3 | 6.4 | Present |
Makamure [37] | 39 | Zimbabwe | Urban | April 2011–March 2012 | Cross-sectional | MGIT and L-J | Sputum | Median 160 (IQR 84–285) | NR | NR | Present |
Moore [38] | 294 | Peru | Urban | April 2003–July 2004 | Cross-sectional | BacT and L-J | Sputum, gastric washing | NR | 38.5 | 32 | Present |
Oberhelman [39] | 44 | Peru | Urban | 2004–2007 | Case–control | L-J | Gastric, nasopharyngeal aspirates, stools | NR | 51.6 | 3 | Present |
Shah [40] | 388 | South Africa | Rural | June 2008–April 2009 | Cross-sectional | MGIT and Middlebrook 7H10 agar | Sputum | Median 161 (IQR 72–307) | NR | NR | Present |
Solomon [41] | 366 | India | Urban | July 2009–March 2010 | Cross-sectional | BACTEC TB 460 | Sputum | NR | 37.5 | 38.5 | Present |
MGIT (mycobacteria growth indicator tube) and BACTEC are manufactured by BD Biosciences (Franklin Lakes, NJ, USA), and BacT is manufactured by bioMerieux (Lyon, France). L-J: Löwenstein-Jensen; CSF: cerebrospinal fluid; NR: not reported; IQR: interquartile range.